Repligen Corp. (RGEN)
143.66
+1.48
(+1.04%)
USD |
NASDAQ |
Feb 09, 16:00
143.66
0.00 (0.00%)
After-Hours: 20:00
Repligen EPS Diluted (Quarterly) : 0.2638 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Enovis Corp. | -9.990 |
| Abbott Laboratories | 1.017 |
| Accuray, Inc. | -0.1138 |
| Alphatec Holdings, Inc. | -0.1888 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 14.91M |
| Revenue (Quarterly) | 188.80M |
| Total Expenses (Quarterly) | 173.89M |
| Enterprise Value | 7.944B |
| Gross Profit Margin (Quarterly) | 47.99% |
| Profit Margin (Quarterly) | 7.90% |
| Earnings Yield | 0.02% |
| Operating Earnings Yield | 0.58% |
| Normalized Earnings Yield | 0.4179 |